LIVMARLI
Google image searchProduct monograph
Active ingredient
maralixibat (maralixibat chloride), 9.5 MG/ML
DIN: 02539888
Dosage form(s): SOLUTION
Route(s) of administration: ORAL
Schedule: Prescription
Company: MIRUM PHARMACEUTICALS, INC.
Date: 11-AUG-2023
ATC:
- A05 — BILE AND LIVER THERAPY (ATC, ATC/DDD, )
- A05A — BILE THERAPY (ATC, ATC/DDD)
- A05AX — Other drugs for bile therapy (ATC, ATC/DDD)
- A05AX04 — MARALIXIMAB CHLORIDE (ATC/DDD)
Reference brand drug: Livmarli
